No Data
No Data
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting
Phio Pharmaceuticals Advances Cancer Therapy, Completes Safety Enrollment in PH-762 Phase 1b Trial
Phio Pharma Analyst Ratings
Positive Outlook for Phio Pharmaceuticals: Promising Clinical Results and Innovative Technology Drive Buy Rating
H.C. Wainwright Maintains Phio Pharmaceuticals(PHIO.US) With Buy Rating, Cuts Target Price to $4
Phio Pharmaceuticals Showcases New Cancer-Fighting Gene Therapy at Industry Event
Unlock the Full List